Exploiting HPV-Induced Carcinogenesis for a Rational Drug Development in Cervical Cancer
Journal:
Current Cancer Drug Targets
Volume:
16
Page:
249-260
Author(s):
A. Nogueira-Rodrigues, A.C. Melo, G. Werutsky, A.H.I. Garces and C.G. Ferreira
Editorial (Thematic Issue: Polymeric Nanomedicines for Malignancy Therapy)
Journal:
Current Pharmaceutical Biotechnology
Volume:
17
Page:
210-211
Author(s):
Jianxun Ding, Xiuli Zhuang and Xuesi Chen
Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in Osteosarcoma
Journal:
Current Cancer Drug Targets
Volume:
16
Page:
261-274
Author(s):
Marilù Fanelli, Claudia Maria Hattinger, Serena Vella, Elisa Tavanti, Francesca Michelacci, Beth Gudeman, Daryl Barnett, Piero Picci and Massimo Serra
Anaesthesia in Cancer Surgery: Can it Affect Cancer Survival?
Journal:
Current Clinical Pharmacology
Volume:
11
Page:
4-20
Author(s):
Bruce Ben-David
Challenges and Successes Using Nanomedicines for Aerosol Delivery to the Airways
Journal:
Current Gene Therapy
Volume:
16
Page:
34-46
Author(s):
P. Resnier, A. Mottais, Y. Sibiril, T. Le Gall and T. Montier
Past, Present, and Future of Targeting Ras for Cancer Therapies
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
16
Page:
345-357
Author(s):
Zhi Tan and Shuxing Zhang
RGD-based Therapy: Principles of Selectivity
Journal:
Current Pharmaceutical Design
Volume:
22
Page:
925-932
Author(s):
Mikhail A. Rubtsov, Marina S. Syrkina and Gjumrakch Aliev
Interleukin-6: A Critical Cytokine in Cancer Multidrug Resistance
Journal:
Current Pharmaceutical Design
Volume:
22
Page:
518-526
Author(s):
Morteza Ghandadi and Amirhossein Sahebkar
MicroRNAs and the Response of Prostate Cancer to Anti-Cancer Drugs
Journal:
Current Drug Targets
Volume:
17
Page:
257-265
Author(s):
Marzia Pennati, Marco Folini, Paolo Gandellini and Nadia Zaffaroni
Therapeutic Value of an Integrin Antagonist in Prostate Cancer
Journal:
Current Drug Targets
Volume:
17
Page:
321-327
Author(s):
Clément-Lacroix Philippe